InMode Launches Evoke

Fusion Marketplace Changes Healthcare Traveler Experience

Fusion Marketplace is a traveler-first driven platform giving healthcare professionals the power to make decisions in their careers that they haven't been able to in the past.

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company

As the first phase in building this global entity, Veranex has acquired three complementary solution providers: Ximedica, Quartesian, and Boston Healthcare Associates. By bringing these companies together, Veranex combines the industry’s key pillars of design and engineering, regulatory, clinical, and market access into a single-source solution.

InMode Ltd. today announced Evoke, a breakthrough non-invasive solution for facial remodeling.

Evoke is the first hands-free device for the face and submental area cleared by the FDA. This advanced radiofrequency-based platform addresses patient aesthetic concerns with uniform and controlled heating of the skin and subdermal tissue.

Dr. Michael Kreindel, InMode Chief Technology Officer, and inventor of Evoke commented, “The idea of a facial hands-free treatment has been circulating in the market for about 8 years. I’m proud that InMode, after years of research and development, is the first company to bring this solution to patients worldwide.”

Evoke delivers the ultimate solution in thermal facial procedures. Patients can not only turn back the hands of time but are now also able to achieve long-lasting structural enhancements to their face without excisional surgery. InMode once again has brought to market another aesthetics industry game changer,” said Dr. Spero Theodorou, InMode Chief Medical Officer and Plastic Surgeon (bodySCULPT, NY).

 

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles